首页 | 本学科首页   官方微博 | 高级检索  
     


Phase II proof-of-concept study of atorvastatin in castration-resistant prostate cancer
Authors:Linda K. Rushworth  Carolyn Loveridge  Mark Salji  Martin MacLeod  Ernest Mui  David Sumpton  Matthew Neilson  Ann Hedley  Laura Alexander  Elaine McCartney  Rachana Patel  Jan Wallace  Christian Delles  Rob Jones  Hing Y. Leung
Affiliation:1. Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK

CRUK Beatson Institute, Glasgow, UK;2. Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK;3. Beatson West of Scotland Cancer Centre, Glasgow, UK

CRUK West of Scotland Clinical Trials Unit, Glasgow, UK;4. CRUK Beatson Institute, Glasgow, UK;5. Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK

CRUK West of Scotland Clinical Trials Unit, Glasgow, UK;6. Beatson West of Scotland Cancer Centre, Glasgow, UK;7. Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK

Abstract:
Keywords:atorvastatin  statins  cholesterol  castration resistant prostate cancer  prostate specific antigen  #PCSM  #ProstateCancer  #uroonc
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号